With the advent of modulator therapy, there have been many reports of people with cystic fibrosis stopping their inhaled antibiotics [101], with a recent paper describing the need for updated guidance for the management of infection in people who use CFTR modulators [102]. This evidence concerns the gene CFTR and infection.